Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade

Real-world evidence (RWE) – conclusions derived from analysis of patients not treated in clinical trials – is increasingly recognized as an opportunity for discovery, to reduce disparities, and to contribute to regulatory approval. Maximal value of RWE may be facilitated through machine learning tec...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer Discov
Prif Awduron: Arbour, Kathryn C., Luu, Anh Tuan, Luo, Jia, Rizvi, Hira, Plodkowski, Andrew J., Sakhi, Mustafa, Huang, Kevin B., Digumarthy, Subba R., Ginsberg, Michelle S., Girshman, Jeffrey, Kris, Mark G., Riely, Gregory J., Yala, Adam, Gainor, Justin F., Barzilay, Regina, Hellmann, Matthew D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7981277/
https://ncbi.nlm.nih.gov/pubmed/32958579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-0419
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg